Shuji Kotoh
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 5
-
- Glutathione Transferases and Polymorphisms 5
- Renal and related cancers 3
- Genomics, phytochemicals, and oxidative stress 3
-
- Bladder and Urothelial Cancer Treatments 9
- Urinary and Genital Oncology Studies 3
-
- Prostate Cancer Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 3
- Co-authors
- Joichi KumazawaSeiji NaitoNaotaka SakamotoAkira YokomizoMichihiko KuwanoKimitoshi KohnoHirofumi KogaShuji Hasegawa
- Cited by
- OncologyUrologyBiochemistry
- Journals
- The Journal of Urology (5 papers)European Urology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Shuji Kotoh
24 papers receiving 458 citations
Peers
Comparison fields: 5 of 64
- Oncology 251
- Urology 24
- Biochemistry 26
- Molecular Biology 243
- Cancer Research 51
Countries citing papers authored by Shuji Kotoh
This map shows the geographic impact of Shuji Kotoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Kotoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Kotoh more than expected).
Fields of papers citing papers by Shuji Kotoh
This network shows the impact of papers produced by Shuji Kotoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Kotoh. The network helps show where Shuji Kotoh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuji Kotoh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 5 | |
| 2 | 2000 | 28 | |
| 3 | 2000 | 11 | |
| 4 | 1999 | 3 | |
| 5 | 1998 | 25 | |
| 6 | 1997 | 3 | |
| 7 | The expression of drug-resistant genes and the acquirement of drug resistance in human bladder cancer cell lines | 1996 | 1 |
| 8 | Establishment of two human renal cell carcinoma cell lines with different chemosensitivity. | 1996 | 8 |
| 9 | 1995 | 79 | |
| 10 | 1995 | 7 | |
| 11 | 1995 | 28 | |
| 12 | 1994 | 3 | |
| 13 | 1994 | 7 | |
| 14 | 1994 | 26 | |
| 15 | 1993 | 27 | |
| 16 | 1993 | 1 | |
| 17 | 1992 | 1 | |
| 18 | 1992 | 21 | |
| 19 | 1992 | 42 | |
| 20 | Is Colorectal cancer risk increasing in urban Ghanaians | 1988 | 3 |
About Shuji Kotoh
Shuji Kotoh is a scholar working on Urology, Oncology, Biochemistry, Surgery and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 473 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Glutathione Transferases and Polymorphisms (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Renal and related cancers (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Urinary and Genital Oncology Studies (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Oncology (251 citations), Urology (24 citations), Biochemistry (26 citations), Molecular Biology (243 citations) and Cancer Research (51 citations). Shuji Kotoh has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Joichi Kumazawa, Seiji Naito, Naotaka Sakamoto, Akira Yokomizo, Michihiko Kuwano, Kimitoshi Kohno, Hirofumi Koga, Shuji Hasegawa, Ken Goto and Susan P.C. Cole. Their work appears in journals such as The Journal of Urology, European Urology, Cancer Chemotherapy and Pharmacology, Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.